Evidence map›Paper›PMID 41439609›Full record

ReviewJournal of cosmetic dermatology2026

An Innovative Formula for Keratosis Pilaris Treatment-A Randomized Controlled Study Based on the "Exfoliation-Dissolution-Repair" Concept.

Fangzhou Liu, Lu Cheng, Jie Yang, Tuowei Li, Jing Li, Xiaojie Zhang, Fengwei Qi, Yuanbai Li, Yang Yang, Yexiang Zhang and 1 more

Abstract readReview
In one paragraph

Review in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fangzhou LiuInstitute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0003-2844-2727
Lu ChengShandong Huawutang Biotechnology Co. Ltd., Ji'nan, People's Republic of China.
Jie YangShandong Huawutang Biotechnology Co. Ltd., Ji'nan, People's Republic of China.
Tuowei LiSouth China University of Technology, Guangzhou, People's Republic of China.ORCID https://orcid.org/0009-0008-5080-8530
Jing LiEviSkin Testing Technology (Beijing) Co. Ltd., Beijing, People's Republic of China.
Xiaojie ZhangEviSkin Testing Technology (Beijing) Co. Ltd., Beijing, People's Republic of China.
Fengwei QiShandong Huawutang Biotechnology Co. Ltd., Ji'nan, People's Republic of China.
Yuanbai LiInstitute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Yang YangInstitute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Yexiang ZhangShandong Huawutang Biotechnology Co. Ltd., Ji'nan, People's Republic of China.
Hong MengInternational School of Cosmetics, Beijing Technology and Business University, Beijing, People's Republic of China.ORCID https://orcid.org/0000-0002-5863-5864

Funding

Key Laboratory of Multi-source Digital and Intelligent Traditional Chinese Medicine Innovation, IICTM, CACMS ZZSYS-1902-01CZMajor Breakthrough Project of the Science and Technology Innovation Project of the Chinese Academy of Chinese Medical Sciences CI2021A05311National Natural Science Foundation Youth Program 82204780Special Program for Training Excellent Young Science and Technology Talents of the Chinese Academy of Traditional Chinese Medicine ZZ15-YQ-052
6 · The paper itself

Abstract

objectiveKeratosis pilaris (KP) is a common follicular keratotic skin disorder characterized by follicular papules and skin roughness, often accompanied by itching and inflammation, significantly affecting appearance and psychological health.

methodsThis 28-day prospective, open-label, randomized controlled study evaluated the effectiveness of a novel combined formula for KP treatment. The formula included a scrub (Olea europaea shell powder, hydrated silica, and papain) and a moisturizing lotion with plant oils (peony seed oil, oat kernel oil, and rice bran oil). Sixty KP patients aged 18-35 were randomly assigned to a control group (salicylic acid body lotion) or a study group (combined formula), with 30 participants each. Evaluations included follicular papule counts, transepidermal water loss (TEWL), and depression scale scores at baseline (D0), day 7 (D7), day 14 (D14), day 21 (D21), and day 28 (D28). After D28, a self-assessment questionnaire was used to compare treatment outcomes.

resultsAccording to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p < 0.05). For TEWL values, a significant simple effect of time was observed in the study group (p = 0.026), whereas the control group showed only a marginal change (p = 0.054). Despite the absence of a significant main group effect (p = 0.287), these results suggest that the study group achieved a greater overall improvement in skin barrier function over time. In the self-assessment, 21 out of 23 indicators had higher effectiveness rates in the study group than the control group, with 96.7% effectiveness in improving skin dryness, smoothness, roughness, freshness, oiliness, and oil control. Depression scale scores were significantly affected by both time and group (p = 0.017 and p = 0.008, respectively), indicating psychological improvement after 28 days.

conclusionThe combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients.

Indexed as

Darier DiseaseEyebrowsPlant OilsAbnormalities, MultipleAdolescentAdultDepressionFemaleHumansMaleProspective StudiesSalicylic AcidSkin CreamTreatment OutcomeWater Loss, InsensibleYoung AdultPlant OilsSalicylic Acidfollicular papuleskeratosis pilarispapainplant oilsscrub

Identifiers

PMID41439609
PMCPMC12729505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.